Results 221 to 230 of about 1,670,952 (313)

Formal and informal social care in people with Rheumatic and Musculoskeletal diseases: a cross‐sectional multicentre survey

Arthritis Care &Research, Accepted Article.
Introduction Rheumatic and musculoskeletal diseases(RMDs) are leading causes of physical disability, necessitating support with activities of daily living(ADLs). This study describes social care received by patients with RMDs in two disperate regions of England: Salford(urban) and Norfolk(rural).
Mehreen Somro, Karen Durrant, William G Dixon, John McBeth, Alex MacGregor, Max Yates, Jenny H Humphreys   +6 more
wiley   +1 more source

Pulmonary Hypertension Associated With Interstitial Lung Diseases. [PDF]

Chest
Jose A, Sood N, Elwing JM, Akkanti B, Bajwa A, Bernardo R, Estrada RA, Sharma M, Soto FJ, Tonelli AR, Verma D, Vintch J, Sahay S, Shlobin OA, Pulmonary Vascular Disease (PVD) Section.   +14 more
europepmc   +1 more source

Characteristics and outcomes of male participants in the Australian Scleroderma Cohort Study (ASCS).

Arthritis Care &Research, Accepted Article.
Objective To determine the differences in demographic, serologic and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods Retrospective observational study using data from the Australian Scleroderma Cohort Study (ASCS). Males (M) were compared to females (F) using chi‐squared, Wilcoxon
Emily Lin, Dylan Hansen, Laura Ross, Gene‐Siew Ngian, Susanna Proudman, Gabor Major, Maryam Tabesh, Mandana Nikpour, Jennifer Walker, Lauren Host, Nava Ferdowsi, Alannah Quinlivan, Wendy Stevens, Joanne Sahhar, Diane Apostolopoulos   +14 more
wiley   +1 more source

Nerandomilast in Autoimmune-Associated Interstitial Lung Diseases: Translating Evidence from Progressive Pulmonary Fibrosis Studies. [PDF]

J Clin Med
Perrotta F, Mariniello DF, Stella GM, Pagliaro R, Scialò F, Liakouli V, Forte G, Ciccia F, Bianco A, D'Agnano V.   +9 more
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical applications, challenges, and future directions

Arthritis Care &Research, Accepted Article.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

Uncovering mirnomes of patients with interstitial lung diseases and an underlying autoimmune process. [PDF]

Respir Res
Sánchez-Pernaute O, Benítez Y, Vadillo Font C, Nieto MA, Cebrián L, López-Muñiz B, Romero-Bueno FI, Godoy H, Laporta R, Del Pozo Abeijón MV, Abásolo Alcázar L, Mínguez P, Rodríguez Nieto MJ.   +12 more
europepmc   +1 more source

Discordance between patient and physician global assessments in early systemic sclerosis

Arthritis Care &Research, Accepted Article.
Objective This study aims to identify factors associated with patient and physician global assessments and discordance between them in systemic sclerosis (SSc). Methods Data from adults with early SSc (< 5 years) from the CONQUER registry were included.
Ellen Romich, Alexis Ogdie, Alisa Stephens‐Shields, Peter A. Merkel, Shervin Assassi, Elana J. Bernstein, Andreea Bujor, Flavia V. Castelino, Lorinda Chung, Luke B. Evnin, Tracy M. Frech, Jessica K. Gordon, Melissa Griffith, Faye N. Hant, Monica L. Harding, Laura K. Hummers, Dinesh Khanna, Kimberly S. Lakin, Dorota J. Lebiedz‐Odrobina, Yiming Luo, Ashima Makol, Maureen D. Mayes, Zsuzsanna H. McMahan, Jerry Molitor, Duncan F. Moore, Julie Paik, Carrie Richardson, Brian Skaug, Ami A. Shah, Ankoor Shah, Virginia Steen, John M. VanBuren, Elizabeth R. Volkmann, Carleigh Zahn, Nora Sandorfi, for the CONQUER Investigators   +35 more
wiley   +1 more source

Evaluation of myocardial fibrosis and cardiac function in fibrotic lung diseases: a prospective study. [PDF]

Sci Rep
Ekiz S, Esen K, Naycı S, Balcı Y, Yüksek HH.   +4 more
europepmc   +1 more source

Lipid Nanoparticles for the Delivery of CRISPR/Cas9 Machinery to Enable Site‐Specific Integration of CFTR and Mutation‐Agnostic Disease Rescue

Advanced Functional Materials, EarlyView.
Lipid nanoparticles (LNPs) are optimized to co‐deliver Cas9‐encoding messenger RNA (mRNA), a single guide RNA (sgRNA) targeting the endogenous cystic fibrosis transmembrane conductance regulator (CFTR) gene, and homologous linear double‐stranded donor DNA (ldsDNA) templates encoding CFTR.
Ruth A. Foley, Paul G. Ayoub, Vrishti Sinha, Colin Juett, Alicia Sanoyca, Emily C. Duggan, Lindsay E. Lathrop, Priyanka Bhatt, Kevin Coote, Beate Illek, Brigitte N. Gomperts, Donald B. Kohn, Steven J. Jonas   +12 more
wiley   +1 more source

Myeloid PDLIM2 repression as a common mechanism of infection susceptibility in lung diseases. [PDF]

Front Immunol
Gao F, Liu X, Sun F, Xiao Y, Xiao G, Qu Z.   +5 more
europepmc   +1 more source